Cell thiab Gene Therapy Biosafety thiab CMC Test
Biosafety, vector, cell{0}}bank, microbial, RCV, thiab tso tawm-txhawb txoj hauv kev rau kev kho mob ntawm tes thiab noob caj noob ces.
Cell & Gene Therapy (CGT) Solutions
Cov kev pab cuam ntawm tes thiab noob caj noob ces yuav tsum tau tsom rau kev tswj hwm tus kab mob -vector txaus ntshai, cell- substrate zoo, microbial kev nyab xeeb, txheej txheem seem, thiab tso tawm- ntsib cov ntaub ntawv. HyQure txhawb nqaex-vivo thiabhauv-vivo CGT workflows nrog cell bank characterization, RCV pathways, viral clearance or inactivation validation where related, AAV-related biosafety testing, microbial testing, and lot-tso tawm kev txhawb nqa.
Vim li cas HyQure - Qhov Zoo
-
CGT-vector thiab xov tooj ntawm tes-kev txhawb nqa hauv txhab nyiaj
Txoj kev txhawb nqa suav nrog cov kab xov tooj ntawm tes thiab lub txhab nyiaj hauv tuam txhab nyiaj, RCL/RCR/RCA/rcAAV kuaj, hauv -vitro thiab hauv - kuaj kab mob vivo, thiab AAV- cuam tshuam txog biosafety uas cuam tshuam rau cov khoom. -
Residual impurity thiab QC txhawb nqa
Lub party-cell residual DNA, HCP lossis HCD- cuam tshuam txog kev txhawb nqa, txheej txheem- kuaj cov residue, thiab QC cov khoom siv tuaj yeem suav nrog qhov muaj feem cuam tshuam rau theem kev pab cuam thiab cov tswv yim tsim khoom. -
Microbial thiab tswj kev tso tawm txhawb nqa
Kev kuaj kab mob microbial, mycoplasma txoj hauv kev, kev txhawb nqa endotoxin, thiab tom qab ntawd -theem ntau- tso tawm cov haujlwm ua haujlwm pab tiv thaiv lub sijhawm yam tsis muaj kev cia siab rau qhov tsis muaj tseeb ntawm kev thov ceev. -
Kev tswj hwm- paub ceeb toom
Cov ntawv ceeb toom tau piav qhia zoo tshaj plaws raws li theem- tsim nyog, tshawb xyuas- npaj txhij, thiab tsim qauv rau kev txhawb nqa cov ntaub ntawv zoo thiab kev tswj hwm- ntsib kev tshuaj xyuas.
Kev pab them nqi kho mob
-
CAR-T / CAR-NK / TCR-T / TIL
ex-vivo engineered lymphocyte cov khoom uas yuav tsum tau vector-txog kev tswj hwm biosafety, kuaj microbial kev nyab xeeb, thiab tso tawm kev txhawb nqa. -
iPSC / MSC thiab lwm yam khoom ntawm tes
Cell-cov kev pab cuam substrate uas xav tau tus kheej, caj ces- ruaj khov, adventitious-tus neeg sawv cev, thiab cov tswv yim sim microbial. -
AAV thiab noob- cov kev pab kho mob
Vector thiab noob- cov kev pabcuam xa tuaj uas yuav xav tau RCV txoj hauv kev, AAV cov yam ntxwv, thiab cov ntaub ntawv tiv thaiv kab mob. -
Theem- txhawb nqa
Preclinical, IND-enabling, clinical, BLA-associated, and commercialization-related testing can be described using the phase- lus tsim nyog.
Core Service Peev xwm
-
Cell bank characterizationMCB, WCB, EOPC, thiab lwm lub xovtooj ntawm tes -cov tswv yim kuaj xyuas nyiaj hauv tuam txhab nyiaj them rau tus kheej, tsis muaj menyuam, mycoplasma, kev ruaj khov ntawm caj ces, cov neeg ua haujlwm adventitious, thiab retrovirus-txoj kev muaj feem cuam tshuam. -
Kev rov ua dua - txoj hauv kev muaj peev xwm kis tus kab mobRCL, RCR, RCA, thiab rcAAV txoj hauv kev nrog txoj kev tsim nyog, kev txhawb nqa kev lees paub, thiab kev tswj xyuas kev qhia rau cov matrices cuam tshuam. -
Viral clearance / inactivation validationTxheej txheem- kev soj ntsuam kev pheej hmoo, ntau- qhia txog kev kawm tsim, thiab kauj ruam- kev ntsuam xyuas tshwj xeeb rau kev tshem tawm kab mob lossis kev tsis ua haujlwm uas cov txheej txheem xav tau. -
Khoom noj khoom haus biosafety, microbial, thiab tso tawm kev txhawb nqaKev kuaj kab mob microbial, hauv vitro lossis hauv vivo kuaj kab mob, txheej txheem-kev txhawb nqa residue, AAV-txog biosafety ntsiab, thiab ntau- tso tawm cov haujlwm ua haujlwm tom qab- cov haujlwm theem.

